What we do Hemant Surgical Industries Ltd manufactures and markets medical equipment and disposables, specializing in renal care, cardiovascular, respiratory, critical care, and radiology. |
Founded in 1,989 |
Market share Key player in medical equipment manufacturing and distribution in India, with expanding presence in renal care and critical care sectors. |
Problem solved Provides essential medical devices and consumables improving patient care in dialysis, critical care, and surgical procedures, filling gaps in quality and availability. |
Top clients or who we serve Hospitals, dialysis centers, and healthcare providers in India and select international markets including Philippines; B2B focused. |
Key management Hanskumar Shamji Shah (Chairman & Managing Director), Kaushik Hanskumar Shah (Whole-time Director & CFO) |
Our journey and innovations Started in 1993 with imports, expanded manufacturing from 1999; developed branded products like Aero Plus; entered international distribution and service agreements post-2022; IPO in 2023. |
Where we operate India with export and distribution agreements in the Philippines, Japan, China, and Singapore. |
Top products or what we offer Dialysis solutions, sterilants, purified water, nebulizers, ECG machines, infusion sets, ventilators, marketed under 'Aero Plus' and in partnership with JMS and others. |
Top brands Aero Plus (medical devices), JMS Meditape (imported brand), SWS-4000A hemodialysis machines (exclusive in West India) |
Raw materials needed Medical-grade plastics, chemicals for dialysis solutions, electronic components for devices. |
Raw materials supplier Suppliers from Japan, China, and Indian manufacturers through established partnerships. |
Recurring vs cyclical contribution Revenue largely recurring from consumables and maintenance services, with some cyclical components in capital equipment sales. |
Our industry position Established SME-listed company with growing footprint in renal care equipment manufacturing and distribution. |
Financial highlights FY 2024-25 revenue Rs. 111.64 crore, net profit Rs. 8.13 crore, demonstrating operational profitability and steady growth. |
Geographical revenue split Primarily Indian market with some exports and international distribution; specific split not disclosed. |
Order book - |
Whats driving growth Expansion of manufacturing capabilities, strategic partnerships for distribution and maintenance, rising demand for renal and critical care equipment. |
Our future plans Focused on scaling manufacturing, enhancing R&D, expanding dialysis centers, and strengthening global distribution agreements. |
Our green promise Committed to safety, health, and environment with continuous investments in automation and energy-efficient technologies. |
Our people and values Diverse workforce with focus on ethics, safety, and continuous learning; implementing fair governance practices. |
Key challenges ahead Competitive medical device market, regulatory compliance, maintaining innovation, and managing supply chain costs. |
Interesting facts Operates five dialysis centers; secured exclusive distribution rights for advanced hemodialysis machines; successfully completed IPO in 2023. |
Risks and strategy Mitigates market and regulatory risks through compliance, diversification of products, and strategic partnerships enhancing competitive edge. |
